Odaily Noon Briefing
1. Only one person has been approved for Trump's "Golden Card" visa program, creating a stark contrast to the expectation of tens of billions of dollars;
2. Pump.fun has repurchased over 35% of the total circulating supply of tokens, with cumulative buybacks exceeding $360 million in value;
3. NVIDIA's market capitalization has once again surpassed $5 trillion;
4. The US military personnel who illegally profited $400,000 on Polymarket was previously denied account opening by Kalshi;
5. Financial reports disclose that Trump conducted dozens of bond trading transactions in March, totaling several million dollars;
6. Bitdeer continues to maintain zero holdings and sold 185.7 BTC this week;
7. Bitcoin developer Paul Sztorc plans to launch the eCash hard fork network in August, supporting 1:1 exchange with BTC, which has sparked community controversy;
8. Mango Markets attacker Avi Eisenberg's address has appeared on-chain again with a new signature, drawing community attention;
9. An early Ethereum whale has transferred 10,000 ETH to a multi-signature address and may sell in the near future;
10. An address linked to the Balancer attacker transferred 5,609 ETH worth $13 million to THORChain over the past 9 hours.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Despite a 16% drop in sales, profit remains stable! Porsche (POAHY.US) maintains its earnings, with the 911 as a key support
Despite another significant decline in car sales, the profitability of the German luxury carmaker Porsche remains stable. The demand for high-end models such as the 911 and its expensive derivative models has helped the company cushion the impact of weak performance in the Chinese market.
Equities: AI optimism lifts global stocks and chipmakers – Danske Bank

USD/JPY Price Forecast: Strives to return above 20-day EMA

Parkinson's disease therapy developer Aspen Neuroscience (ASPE.US) sets IPO price at $15-17 per share, aiming to raise $150 million
Aspen Neuroscience has announced its IPO terms.
